The co-expression of ERß2 and IL-12Rß2 is better prognostic factor in non-small-cell lung cancer progression.
Med Oncol
; 30(3): 592, 2013.
Article
em En
| MEDLINE
| ID: mdl-23677568
ABSTRACT
Estrogens and IL-12 play a pivotal role in the development and progression of non-small-cell lung cancer (NSCLC); at the same time, estrogen receptor ß2 and (interleukin-12 receptor ß2)IL-12Rß2 are their important receptors, respectively. With the functions of ERß2 and IL-12Rß2 explored further in NSCLC, some questions on the relation between ERß2 and IL-12Rß2 expression need to be solved. In this study, our aim is to elucidate relationship and roles of ERß2 and IL-12Rß2 in NSCLC. The expression of estrogen receptors ß2 and IL-12Rß2 was confirmed by Western blot and RT-PCR analysis in frozen tissues. The correlation between their expression levels and clinical characteristics was evaluated by Mann-Whitney and Kruskal-Wallis test. Using Kaplan-Meier plots and Cox proportional hazard models analyses, overall survival (OS) was evaluated. In contrast to benign pulmonary, ERß2 and IL-12Rß2 were over-expressed in NSCLC (p = 0.000). IHC results showed significant correlation between ERß2 and IL-12Rß2 (R = 0.382, p = 0.005). By analyzing the relation between ERß2, IL-12Rß2 mRNA expression levels and clinical characteristics, it was revealed that ERß2 and IL-12Rß2 were significant correlated with regional lymph node metastasis, T stage and clinical stage (p = 0.000/0.000; 0.001/0.000; 0.031/0.003 respectively), and both protein expression levels were lower with TNM stage being higher. In a Kaplan-Meier analysis, compared to both ERß2 and IL-12Rß2 or one low expression, high expression levels of ERß2 and IL-12Rß2 were identified in a group of patients with the longest overall survival (OS). Cox proportional hazard models revealed that ERß2 and IL-12Rß5 had longer OS. This is the first study to uncover that both ERß2 and IL-12Rß2 were over-expressed and further show that they were co-expressed in NSCLC. Moreover, we found that high expression levels of ERß2 and IL-12Rß2 may be positively correlated with OS and have prognostic values for the progression of NSCLC.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Carcinoma Pulmonar de Células não Pequenas
/
Receptor beta de Estrogênio
/
Receptores de Interleucina-12
/
Neoplasias Pulmonares
Tipo de estudo:
Prognostic_studies
Limite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Med Oncol
Assunto da revista:
NEOPLASIAS
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
China